Molecular profiling of alpha-synuclein pathology and seeding activity in Parkinson’s disease
Acta Neuropathologica · 12.05.2026 · 151 (1)
DOI: 10.1007/s00401-026-03026-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 12.05.2026. Verfasst von Zeynep Bengisu Kaya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Parkinson's disease (PD) is neuropathologically characterized by the abnormal accumulation of fibrillar alpha-synuclein (aSyn) within selectively vulnerable neuronal populations. Although this pathological hallmark is shared across individuals with PD, the disease presents with marked clinical heterogeneity in age of onset, progression rate, and clinical symptoms, the molecular basis of which remains incompletely understood. In this study, we examined whether biochemical and seeding-related properties of aSyn vary across clinically defined PD subgroups. Using well-characterized, autopsy-confirmed PD cases and matched controls we applied complementary biochemical, cell-based aggregation, and cell-free seed amplification assays (SAA) to investigate aSyn molecular heterogeneity and its potential contribution to disease diversity. Autopsy-confirmed PD cases were classified as early-onset ( 60 years), with the late-onset group further subdivided into fast-progressing ( 10 years duration). Analysis of detergent-insoluble fractions from PD brains revealed significantly elevated pSer129-aSyn levels compared to controls, while total aSyn was highest in late-onset PD. Seeding bioactivity measured via FRET-based biosensor cells was significantly increased in PD, albeit with substantial inter-individual variability; late-onset and slow-progressing groups exhibited the strongest activity. Seeding activity correlated positively with pSer129-aSyn levels. These findings were supported by high-content imaging, which demonstrated increased intracellular aggregate burden in PD samples. SAA confirmed robust seeding activity in PD, with shorter lag times relative to controls. Finally, proteinase K digestion of amplified products revealed differences in proteolytic resistance between PD and control samples, consistent with biochemical heterogeneity of seeding-competent species. Collectively, these findings suggest that aSyn pathology in PD is associated with marked inter-individual variability in biochemical and seeding properties. Our results highlight the importance of considering molecular heterogeneity at the individual patient level when investigating PD pathobiology and supports the need for precision medicine approaches for PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA.
- Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.
- Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA. mclean.pamela@mayo.edu.
- Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA. mclean.pamela@mayo.edu.
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- National Institute of Neurological Disorders and Stroke
- American Brain Foundation
Zitieren
APA
Kaya, Z. B., Amerna, D., Susarla, A., Lim, M. J., Bregendahl, M., Sekiya, H., DeTure, M., Ross, O. A., Dickson, D. W., Boschen, S. L., & McLean, P. J. (2026). Molecular profiling of alpha-synuclein pathology and seeding activity in Parkinson’s disease. Acta Neuropathologica, 151(1). https://doi.org/10.1007/s00401-026-03026-1
Vancouver
Kaya ZB, Amerna D, Susarla A, Lim MJ, Bregendahl M, Sekiya H, et al. Molecular profiling of alpha-synuclein pathology and seeding activity in Parkinson’s disease. Acta Neuropathologica. 2026;151(1). doi:10.1007/s00401-026-03026-1
BibTeX
@article{Kaya2026,
author = {Kaya, Zeynep Bengisu and Amerna, Danilyn and Susarla, Ananya and Lim, Melina J and Bregendahl, Maria and Sekiya, Hiroaki and DeTure, Michael and Ross, Owen A and Dickson, Dennis W and Boschen, Suelen L and McLean, Pamela J},
title = {Molecular profiling of alpha-synuclein pathology and seeding activity in Parkinson’s disease},
journal = {Acta Neuropathologica},
year = {2026},
volume = {151},
number = {1},
doi = {10.1007/s00401-026-03026-1}
}
EUVIMED